Media-OutReach Newswire Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
Media-OutReach Newswire The United Laboratories International Holdings Limited Applies for the Clinical Trial of its Class 1 Innovative New Drug UBT251 Injection
Society Localities to ensure funds for vaccines in expanded programme on immunisation: Ministry of Finance